Quarter Financials
Acer Therapeutics Inc. (ACER)
$0.75
-0.04 (-5.18%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Net Income | -5 | -3 | -9 | -4 | -3 | -3 | -2 | -6 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -131 | -126 | -124 | -115 | -110 | -104 | -101 | -99 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Capital Expenditure | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
|---|
| Net PPE | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
|---|